106 related articles for article (PubMed ID: 12193309)
1. Rectal administration of propylthiouracil in hyperthyroid patients: comparison of suspension enema and suppository form.
Jongjaroenprasert W; Akarawut W; Chantasart D; Chailurkit L; Rajatanavin R
Thyroid; 2002 Jul; 12(7):627-31. PubMed ID: 12193309
[TBL] [Abstract][Full Text] [Related]
2. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
Abuid J; Larsen PR
J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
[TBL] [Abstract][Full Text] [Related]
3. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
5. Effects of amiodarone on serum T3 and T4 concentrations in hyperthyroid patients treated with propylthiouracil.
Van Reeth O; Unger J
Thyroid; 1991; 1(4):301-6. PubMed ID: 1841729
[TBL] [Abstract][Full Text] [Related]
6. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
[TBL] [Abstract][Full Text] [Related]
7. Rectal absorption of propylthiouracil.
Bartle WR; Walker SE; Silverberg JD
Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):285-7. PubMed ID: 3410604
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests.
Gardner DF; Cruikshank DP; Hays PM; Cooper DS
J Clin Endocrinol Metab; 1986 Jan; 62(1):217-20. PubMed ID: 3940267
[TBL] [Abstract][Full Text] [Related]
9. Effects of propylthiouracil and relatively small doses of iodide on early phase treatment of hyperthyroidism.
Kasai K; Suzuki H; Shimoda SI
Acta Endocrinol (Copenh); 1980 Mar; 93(3):315-21. PubMed ID: 7376794
[TBL] [Abstract][Full Text] [Related]
10. Rectal administration of propylthiouracil in suppository form in patients with thyrotoxicosis and critical illness: case report and review of literature.
Zweig SB; Schlosser JR; Thomas SA; Levy CJ; Fleckman AM
Endocr Pract; 2006; 12(1):43-7. PubMed ID: 16524862
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of propylthiouracil in normal and hyperthyroid subjects after a single oral dose.
McMurry JF; Gilliland PF; Ratliff CR; Bourland PD
J Clin Endocrinol Metab; 1975 Aug; 41(2):362-4. PubMed ID: 1159047
[TBL] [Abstract][Full Text] [Related]
12. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
13. Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial.
Bonnema SJ; Bennedbaek FN; Veje A; Marving J; Hegedüs L
J Clin Endocrinol Metab; 2004 Sep; 89(9):4439-44. PubMed ID: 15356044
[TBL] [Abstract][Full Text] [Related]
14. Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism.
Nicholas WC; Fischer RG; Stevenson RA; Bass JD
South Med J; 1995 Sep; 88(9):973-6. PubMed ID: 7660219
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of inhibition of iodothyronine deiodination during propylthiouracil treatment of thyrotoxicosis.
Laurberg P; Weeke J
Horm Metab Res; 1981 May; 13(5):289-92. PubMed ID: 7262827
[TBL] [Abstract][Full Text] [Related]
16. Effect of cimetidine on prolactin secretion in normal controls and hyperthyroid patients.
Kamijo K; Saito A; Kato T; Kawasaki K; Suzuki M; Yabana T; Yachi A; Wada T
Endocrinol Jpn; 1982 Apr; 29(2):177-81. PubMed ID: 7128538
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil.
Israel Y; Walfish PG; Orrego H; Blake J; Kalant H
Gastroenterology; 1979 Jan; 76(1):116-22. PubMed ID: 758132
[TBL] [Abstract][Full Text] [Related]
18. Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases.
Laurberg P; Vestergaard H; Nielsen S; Christensen SE; Seefeldt T; Helleberg K; Pedersen KM
J Clin Endocrinol Metab; 2007 Jun; 92(6):2149-56. PubMed ID: 17389703
[TBL] [Abstract][Full Text] [Related]
19. Effects of propylthiouracil on intestinal transit time and symptoms in hyperthyroid patients.
Papa A; Cammarota G; Tursi A; Certo M; Montalto M; Capelli G; de Rosa G; Cuoco L; Fedeli G; Gasbarrini G
Hepatogastroenterology; 1997; 44(14):426-9. PubMed ID: 9164513
[TBL] [Abstract][Full Text] [Related]
20. Administration of equally divided doses of propylthiouracil every two-eight hours in hyperthyroidism.
Mendoza-Morfin F; Bonilla-Lajud I; Callejas-Ramos F; Ortigosa-Ramírez JL; Oseguera-Valladares R; Gutiérrez-Perez HM; Escobar-Cauz G
Arch Invest Med (Mex); 1979; 10(3):127-34. PubMed ID: 386974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
